Jeanne Fourie Zirkelbach
7PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Oct 08, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.Sundeep Agrawal, Clara Lee, William F Pierce
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Nov 17, 2023
Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development.Huiming Xia, Brian P Booth, Yaning Wang
|Jun 02, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.Elizabeth S Duke, Diana Bradford, Michelle Marcovitz
|Oct 07, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.Timil H Patel, Leigh Marcus, M Naomi Horiba
Pageof 2
Frequent Collaborators
6 joint publications
Richard Pazdur
4 joint publications
Barbara Scepura
4 joint publications
Harpreet Singh
4 joint publications
Youwei Bi
4 joint publications
Pallavi S Mishra-Kalyani
3 joint publications
Idara Ojofeitimi
3 joint publications
Diana Bradford
3 joint publications
Yangbing Li
3 joint publications
Anup K Amatya
3 joint publications
Nicole Drezner
